Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Scott Cotler MD
Scott J. Cotler MD Associate Editor
Gail Hecht MD
Gail Hecht MD Editor-in-Chief
Steven Edmundowicz MD, MASGE
Steven A. Edmundowicz MD, MASGE Associate Editor
See All Experts
featured
Published in Gastroenterology

Journal Scan / Research · June 22, 2022

Direct Healthcare Costs of IBS in the UK

Alimentary Pharmacology & Therapeutics

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Amit Patel MD

Alimentary Pharmacology & Therapeutics
Direct healthcare costs of Rome IV or Rome III-defined irritable bowel syndrome in the United Kingdom
Aliment. Pharmacol. Ther. 2022 Jul 01;56(1)110-120, VC Goodoory, CE Ng, CJ Black, AC Ford

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated